Chandra Bhagat Pharma Statistics
Total Valuation
BOM:542934 has a market cap or net worth of INR 305.57 million. The enterprise value is 491.00 million.
| Market Cap | 305.57M |
| Enterprise Value | 491.00M |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:542934 has 7.55 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 7.55M |
| Shares Outstanding | 7.55M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | -1.04% |
| Owned by Insiders (%) | 73.76% |
| Owned by Institutions (%) | 7.30% |
| Float | 1.30M |
Valuation Ratios
The trailing PE ratio is 48.99.
| PE Ratio | 48.99 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | 21.29 |
| P/OCF Ratio | 11.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.16, with an EV/FCF ratio of 34.22.
| EV / Earnings | 78.94 |
| EV / Sales | 0.99 |
| EV / EBITDA | 15.16 |
| EV / EBIT | 22.74 |
| EV / FCF | 34.22 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.49 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 6.52 |
| Debt / FCF | 14.71 |
| Interest Coverage | 1.23 |
Financial Efficiency
Return on equity (ROE) is 2.07% and return on invested capital (ROIC) is 2.34%.
| Return on Equity (ROE) | 2.07% |
| Return on Assets (ROA) | 1.48% |
| Return on Invested Capital (ROIC) | 2.34% |
| Return on Capital Employed (ROCE) | 6.92% |
| Weighted Average Cost of Capital (WACC) | 1.73% |
| Revenue Per Employee | 12.35M |
| Profits Per Employee | 155,500 |
| Employee Count | 40 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 19.27 |
Taxes
In the past 12 months, BOM:542934 has paid 5.51 million in taxes.
| Income Tax | 5.51M |
| Effective Tax Rate | 46.95% |
Stock Price Statistics
The stock price has decreased by -38.64% in the last 52 weeks. The beta is -0.80, so BOM:542934's price volatility has been lower than the market average.
| Beta (5Y) | -0.80 |
| 52-Week Price Change | -38.64% |
| 50-Day Moving Average | 48.48 |
| 200-Day Moving Average | 67.79 |
| Relative Strength Index (RSI) | 43.68 |
| Average Volume (20 Days) | 6,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542934 had revenue of INR 493.95 million and earned 6.22 million in profits. Earnings per share was 0.83.
| Revenue | 493.95M |
| Gross Profit | 136.59M |
| Operating Income | 21.59M |
| Pretax Income | 11.73M |
| Net Income | 6.22M |
| EBITDA | 32.40M |
| EBIT | 21.59M |
| Earnings Per Share (EPS) | 0.83 |
Balance Sheet
The company has 25.72 million in cash and 211.14 million in debt, with a net cash position of -185.42 million or -24.58 per share.
| Cash & Cash Equivalents | 25.72M |
| Total Debt | 211.14M |
| Net Cash | -185.42M |
| Net Cash Per Share | -24.58 |
| Equity (Book Value) | 304.18M |
| Book Value Per Share | 40.64 |
| Working Capital | 279.44M |
Cash Flow
In the last 12 months, operating cash flow was 26.67 million and capital expenditures -12.32 million, giving a free cash flow of 14.35 million.
| Operating Cash Flow | 26.67M |
| Capital Expenditures | -12.32M |
| Free Cash Flow | 14.35M |
| FCF Per Share | 1.90 |
Margins
Gross margin is 27.65%, with operating and profit margins of 4.37% and 1.26%.
| Gross Margin | 27.65% |
| Operating Margin | 4.37% |
| Pretax Margin | 2.37% |
| Profit Margin | 1.26% |
| EBITDA Margin | 6.56% |
| EBIT Margin | 4.37% |
| FCF Margin | 2.91% |
Dividends & Yields
BOM:542934 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.06% |
| Earnings Yield | 2.04% |
| FCF Yield | 4.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |